{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:02:58Z","timestamp":1790737378683,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0F8516N"],"award-info":[{"award-number":["G0F8516N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002913","name":"Vlaamse Overheid","doi-asserted-by":"publisher","award":["IWT 135043"],"award-info":[{"award-number":["IWT 135043"]}],"id":[{"id":"10.13039\/501100002913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00401-020-02251-6","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T02:15:05Z","timestamp":1610331305000},"page":"173-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation"],"prefix":"10.1007","volume":"141","author":[{"given":"Luis","family":"Arag\u00e3o Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-2079","authenticated-orcid":false,"given":"Valerie","family":"Uytterhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Lopez-Sanmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra O.","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-2502","authenticated-orcid":false,"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vandenbulcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8614-2223","authenticated-orcid":false,"given":"Christine A. F.","family":"von Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Verstreken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-1075","authenticated-orcid":false,"given":"Dietmar Rudolf","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H et al (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe consortium. Brain Pathol 18:484\u2013496. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00147.x","journal-title":"Brain Pathol"},{"key":"2251_CR2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/01.jnen.0000229986.17548.27","volume":"65","author":"I Alafuzoff","year":"2006","unstructured":"Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I et al (2006) Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe consortium. J Neuropathol Exp Neurol 65:740\u2013757. https:\/\/doi.org\/10.1097\/01.jnen.0000229986.17548.27","journal-title":"J Neuropathol Exp Neurol"},{"key":"2251_CR3","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1523\/jneurosci.23-18-06972.2003","volume":"23","author":"T Arendt","year":"2003","unstructured":"Arendt T, Stieler J, Strijkstra AM, Hut RA, R\u00fcdiger J, Van der Zee EA et al (2003) Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 23:6972\u20136981. https:\/\/doi.org\/10.1523\/jneurosci.23-18-06972.2003","journal-title":"J Neurosci"},{"key":"2251_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","volume":"103","author":"JC Augustinack","year":"2002","unstructured":"Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease. Acta Neuropathol 103:26\u201335. https:\/\/doi.org\/10.1007\/s004010100423","journal-title":"Acta Neuropathol"},{"key":"2251_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VMY, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8:663\u2013672","journal-title":"Nat Rev Neurosci"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0006-8993(89)91396-6","volume":"477","author":"C Bancher","year":"1989","unstructured":"Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G et al (1989) Accumulation of abnormally phosphorylated \u03c4 precedes the formation of neurofibrillary tangles in Alzheimer\u2019s disease. Brain Res 477:90\u201399. https:\/\/doi.org\/10.1016\/0006-8993(89)91396-6","journal-title":"Brain Res"},{"key":"2251_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/BF00293315","volume":"87","author":"E Braak","year":"1994","unstructured":"Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554\u2013567. https:\/\/doi.org\/10.1007\/BF00293315","journal-title":"Acta Neuropathol"},{"key":"2251_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"2251_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2251_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","volume":"1","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213\u2013216. https:\/\/doi.org\/10.1111\/j.1750-3639.1991.tb00661.x","journal-title":"Brain Pathol"},{"key":"2251_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960\u2013969. https:\/\/doi.org\/10.1097\/NEN.0b013e318232a379","journal-title":"J Neuropathol Exp Neurol"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","volume":"121","author":"H Braak","year":"2011","unstructured":"Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer\u2019s disease in individuals under thirty. Acta Neuropathol 121:171\u2013181. https:\/\/doi.org\/10.1007\/s00401-010-0789-4","journal-title":"Acta Neuropathol"},{"key":"2251_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"2251_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrn3887","volume":"16","author":"J Brettschneider","year":"2015","unstructured":"Brettschneider J, Del Tredici K, Lee VMY, Trojanowski JQ (2015) Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16:109\u2013120","journal-title":"Nat Rev Neurosci"},{"key":"2251_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A De Calignon","year":"2012","unstructured":"De Calignon A, Polydoro M, Su\u00e1rez-Calvet M, William C, Adamowicz DH, Kopeikina KJ et al (2012) Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73:685\u2013697. https:\/\/doi.org\/10.1016\/j.neuron.2011.11.033","journal-title":"Neuron"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV et al (2013) Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 18:1225\u20131234. https:\/\/doi.org\/10.1038\/mp.2013.1","journal-title":"Mol Psychiatry"},{"key":"2251_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M et al (2020) PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol 139:503\u2013526. https:\/\/doi.org\/10.1007\/s00401-019-02114-9","journal-title":"Acta Neuropathol"},{"key":"2251_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. https:\/\/doi.org\/10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"2251_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K et al (2004) LRP\/amyloid \u03b2-peptide interaction mediates differential brain efflux of A\u03b2 isoforms. Neuron 43:333\u2013344. https:\/\/doi.org\/10.1016\/j.neuron.2004.07.017","journal-title":"Neuron"},{"key":"2251_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2018.00267","volume":"12","author":"SL DeVos","year":"2018","unstructured":"DeVos SL, Corjuc BT, Oakley DH, Nobuhara CK, Bannon RN, Chase A et al (2018) Synaptic tau seeding precedes tau pathology in human Alzheimer\u2019s disease brain. Front Neurosci 12:267. https:\/\/doi.org\/10.3389\/fnins.2018.00267","journal-title":"Front Neurosci"},{"key":"2251_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Kouri N, Murray ME, Josephs KA (2011) Neuropathology of frontotemporal lobar degeneration-Tau (FTLD-Tau). J Mol Neurosci 45:384\u2013389.\u00a0https:\/\/doi.org\/10.1007\/s12031-011-9589-0","journal-title":"J Mol Neurosci"},{"key":"2251_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","volume":"129","author":"C Duyckaerts","year":"2015","unstructured":"Duyckaerts C, Braak H, Brion JP, Bu\u00e9e L, Del Tredici K, Goedert M et al (2015) PART is part of Alzheimer disease. Acta Neuropathol 129:749\u2013756. https:\/\/doi.org\/10.1007\/s00401-015-1390-7","journal-title":"Acta Neuropathol"},{"key":"2251_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ et al (2017) Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547:185\u2013190. https:\/\/doi.org\/10.1038\/nature23002","journal-title":"Nature"},{"key":"2251_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa011","author":"EB Glennon","year":"2020","unstructured":"Glennon EB, Lau DHW, Gabriele RMC, Taylor MF, Troakes C, Opie-Martin S et al (2020) Bridging integrator 1 protein loss in Alzheimer\u2019s disease promotes synaptic tau accumulation and disrupts tau release. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcaa011","journal-title":"Brain Commun"},{"key":"2251_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00401-019-02053-5","volume":"138","author":"LA Gomes","year":"2019","unstructured":"Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ et al (2019) A\u03b2-induced acceleration of Alzheimer-related \u03c4-pathology spreading and its association with prion protein. Acta Neuropathol 138:913\u2013941. https:\/\/doi.org\/10.1007\/s00401-019-02053-5","journal-title":"Acta Neuropathol"},{"key":"2251_CR26","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, Van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A\u03b242 fibrils. Science 293:1491\u20131495. https:\/\/doi.org\/10.1126\/science.1062097","journal-title":"Science"},{"key":"2251_CR27","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","volume":"261","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084\u20136089","journal-title":"J Biol Chem"},{"key":"2251_CR28","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B et al (2016) Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice. J Exp Med 213:2635\u20132654. https:\/\/doi.org\/10.1084\/jem.20160833","journal-title":"J Exp Med"},{"key":"2251_CR29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665\u2013704. https:\/\/doi.org\/10.1007\/s00401-017-1707-9","journal-title":"Acta Neuropathol"},{"key":"2251_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL et al (1992) Amyloid \u03b2-peptide is produced by cultured cells during normal metabolism. Nature 359:322\u2013325. https:\/\/doi.org\/10.1038\/359322a0","journal-title":"Nature"},{"key":"2251_CR31","doi-asserted-by":"publisher","first-page":"e45881","DOI":"10.1371\/journal.pone.0045881","volume":"7","author":"JA Harris","year":"2012","unstructured":"Harris JA, Koyama A, Maeda S, Ho K, Devidze N, Dubal DB et al (2012) Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits. PLoS ONE 7:e45881. https:\/\/doi.org\/10.1371\/journal.pone.0045881","journal-title":"PLoS ONE"},{"key":"2251_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.brainres.2005.07.017","volume":"1056","author":"W H\u00e4rtig","year":"2005","unstructured":"H\u00e4rtig W, Oklejewicz M, Strijkstra AM, Boerema AS, Stieler J, Arendt T (2005) Phosphorylation of the tau protein sequence 199\u2013205 in the hippocampal CA3 region of Syrian hamsters in adulthood and during aging. Brain Res 1056:100\u2013104. https:\/\/doi.org\/10.1016\/j.brainres.2005.07.017","journal-title":"Brain Res"},{"key":"2251_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L et al (2018) Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med 24:29\u201338. https:\/\/doi.org\/10.1038\/nm.4443","journal-title":"Nat Med"},{"key":"2251_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbadis.2004.06.015","volume":"1739","author":"BT Hyman","year":"2005","unstructured":"Hyman BT, Augustinack JC, Ingelsson M (2005) Transcriptional and conformational changes of the tau molecule in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1739:150\u2013157","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2251_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimer\u2019s Dement"},{"key":"2251_CR36","doi-asserted-by":"publisher","first-page":"32066","DOI":"10.1074\/jbc.M805300200","volume":"283","author":"S Jeganathan","year":"2008","unstructured":"Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow EM, Mandelkow E (2008) Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of tau and generates a pathological (MC-1) conformation. J Biol Chem 283:32066\u201332076. https:\/\/doi.org\/10.1074\/jbc.M805300200","journal-title":"J Biol Chem"},{"key":"2251_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-018-1894-z","volume":"136","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Different patterns of hippocampal tau pathology in Alzheimer\u2019s disease and PART. Acta Neuropathol 136:811\u2013813","journal-title":"Acta Neuropathol"},{"key":"2251_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-016-1632-3","volume":"132","author":"DJ Koss","year":"2016","unstructured":"Koss DJ, Jones G, Cranston A, Gardner H, Kanaan NM, Platt B (2016) Soluble pre-fibrillar tau and \u03b2-amyloid species emerge in early human Alzheimer\u2019s disease and track disease progression and cognitive decline. Acta Neuropathol 132:875\u2013895. https:\/\/doi.org\/10.1007\/s00401-016-1632-3","journal-title":"Acta Neuropathol"},{"key":"2251_CR39","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"2251_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fnmol.2018.00421","volume":"11","author":"A Lasorsa","year":"2018","unstructured":"Lasorsa A, Malki I, Cantrelle F-X, Merzougui H, Boll E, Lambert J-C et al (2018) Structural basis of tau interaction with BIN1 and regulation by tau phosphorylation. Front Mol Neurosci 11:421. https:\/\/doi.org\/10.3389\/fnmol.2018.00421","journal-title":"Front Mol Neurosci"},{"key":"2251_CR41","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2353\/ajpath.2007.070345","volume":"171","author":"K Leroy","year":"2007","unstructured":"Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R et al (2007) Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol 171:976\u2013992. https:\/\/doi.org\/10.2353\/ajpath.2007.070345","journal-title":"Am J Pathol"},{"key":"2251_CR42","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487\u20131491. https:\/\/doi.org\/10.1126\/science.1058189","journal-title":"Science"},{"key":"2251_CR43","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/emboj.2011.376","volume":"30","author":"X Li","year":"2011","unstructured":"Li X, Kumar Y, Zempel H, Mandelkow EM, Biernat J, Mandelkow E (2011) Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration. EMBO J 30:4825\u20134837. https:\/\/doi.org\/10.1038\/emboj.2011.376","journal-title":"EMBO J"},{"key":"2251_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JAD-2007-12410","volume":"12","author":"J Luna-Mu\u00f1oz","year":"2007","unstructured":"Luna-Mu\u00f1oz J, Ch\u00e1vez-Mac\u00edas L, Garc\u00eda-Sierra F, Mena R (2007) Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 12:365\u2013375. https:\/\/doi.org\/10.3233\/JAD-2007-12410","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2251_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-2005-8104","volume":"8","author":"J Luna-Mu\u00f1oz","year":"2005","unstructured":"Luna-Mu\u00f1oz J, Garc\u00eda-Sierra F, Falc\u00f3n V, Men\u00e9ndez I, Ch\u00e1vez-Mac\u00edas L, Mena R (2005) Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 8:29\u201341. https:\/\/doi.org\/10.3233\/JAD-2005-8104","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2251_CR46","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245\u20134249. https:\/\/doi.org\/10.1073\/pnas.82.12.4245","journal-title":"Proc Natl Acad Sci USA"},{"key":"2251_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/J.NEURON.2018.01.022","volume":"97","author":"J McInnes","year":"2018","unstructured":"McInnes J, Wierda K, Snellinx A, Bounti L, Wang Y-C, Stancu I-C et al (2018) Synaptogyrin-3 mediates presynaptic dysfunction induced by tau. Neuron 97:823-835.e8. https:\/\/doi.org\/10.1016\/J.NEURON.2018.01.022","journal-title":"Neuron"},{"key":"2251_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimer\u2019s Dement"},{"key":"2251_CR49","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"2251_CR50","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/wnl.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G et al (1989) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology 39:1159\u20131165. https:\/\/doi.org\/10.1212\/wnl.39.9.1159","journal-title":"Neurology"},{"key":"2251_CR51","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/780102","author":"KJ Oh","year":"2010","unstructured":"Oh KJ, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ (2010) Staging of Alzheimer\u2019s pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimers Dis. https:\/\/doi.org\/10.4061\/2010\/780102","journal-title":"Int J Alzheimers Dis"},{"key":"2251_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","volume":"6","author":"J Neddens","year":"2018","unstructured":"Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T et al (2018) Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease. Acta Neuropathol Commun 6:52. https:\/\/doi.org\/10.1186\/s40478-018-0557-6","journal-title":"Acta Neuropathol Commun"},{"key":"2251_CR53","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142:1503\u20131527. https:\/\/doi.org\/10.1093\/brain\/awz099","journal-title":"Brain"},{"key":"2251_CR54","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","volume":"29","author":"EK Pickett","year":"2019","unstructured":"Pickett EK, Herrmann AG, McQueen J, Abt K, Dando O, Tulloch J et al (2019) Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer\u2019s disease. Cell Rep 29:3592-3604.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.044","journal-title":"Cell Rep"},{"key":"2251_CR55","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s004010050565","volume":"92","author":"A Probst","year":"1996","unstructured":"Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG (1996) Pick\u2019s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 92:588\u2013596. https:\/\/doi.org\/10.1007\/s004010050565","journal-title":"Acta Neuropathol"},{"key":"2251_CR56","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/00005072-199806000-00006","volume":"57","author":"LA Reed","year":"1998","unstructured":"Reed LA, Schmidt ML, Wszolek ZK, Balin BJ, Soontornniyomkij V, Lee VMY et al (1998) The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia (\u2018pallido-ponto-nigral degeneration\u2019). J Neuropathol Exp Neurol 57:588\u2013601. https:\/\/doi.org\/10.1097\/00005072-199806000-00006","journal-title":"J Neuropathol Exp Neurol"},{"key":"2251_CR57","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/J.NEUROBIOLAGING.2011.12.032","volume":"33","author":"A Rijal Upadhaya","year":"2012","unstructured":"Rijal Upadhaya A, Capetillo-Zarate E, Kosterin I, Abramowski D, Kumar S, Yamaguchi H et al (2012) Dispersible amyloid \u03b2-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Neurobiol Aging 33:2641\u20132660. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2011.12.032","journal-title":"Neurobiol Aging"},{"key":"2251_CR58","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/brain\/awt362","volume":"137","author":"A Rijal Upadhaya","year":"2014","unstructured":"Rijal Upadhaya A, Kosterin I, Kumar S, Von Arnim CAF, Yamaguchi H, F\u00e4ndrich M et al (2014) Biochemical stages of amyloid-\u03b2 peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer\u2019s disease. Brain 137:887\u2013903. https:\/\/doi.org\/10.1093\/brain\/awt362","journal-title":"Brain"},{"key":"2251_CR59","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/brain\/awx057","volume":"140","author":"BR Roberts","year":"2017","unstructured":"Roberts BR, Lind M, Wagen AZ, Rembach A, Frugier T, Li QX et al (2017) Biochemically-defined pools of amyloid-\u03b2 in sporadic Alzheimer\u2019s disease: correlation with amyloid PET. Brain 140:1486\u20131498. https:\/\/doi.org\/10.1093\/brain\/awx057","journal-title":"Brain"},{"key":"2251_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02017-9","author":"M Sartori","year":"2019","unstructured":"Sartori M, Mendes T, Desai S, Lasorsa A, Herledan A, Malmanche N et al (2019) BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02017-9","journal-title":"Acta Neuropathol"},{"key":"2251_CR61","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00018-014-1610-7","volume":"71","author":"T Scholz","year":"2014","unstructured":"Scholz T, Mandelkow E (2014) Transport and diffusion of Tau protein in neurons. Cell Mol Life Sci 71:3139\u20133150","journal-title":"Cell Mol Life Sci"},{"key":"2251_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-015-0237-8","volume":"3","author":"Y Sottejeau","year":"2015","unstructured":"Sottejeau Y, Bretteville A, Cantrelle FX, Malmanche N, Demiaute F, Mendes T et al (2015) Tau phosphorylation regulates the interaction between BIN1\u2019s SH3 domain and Tau\u2019s proline-rich domain. Acta Neuropathol Commun 3:58. https:\/\/doi.org\/10.1186\/s40478-015-0237-8","journal-title":"Acta Neuropathol Commun"},{"key":"2251_CR63","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7:280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","journal-title":"Alzheimer\u2019s Dement"},{"key":"2251_CR64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205. https:\/\/doi.org\/10.1007\/s00401-017-1709-7","journal-title":"Acta Neuropathol"},{"key":"2251_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/jnen\/61.1.33","volume":"61","author":"M Takahashi","year":"2002","unstructured":"Takahashi M, Weidenheim KM, Dickson DW, Ksiezak-Reding H (2002) Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy. J Neuropathol Exp Neurol 61:33\u201345. https:\/\/doi.org\/10.1093\/jnen\/61.1.33","journal-title":"J Neuropathol Exp Neurol"},{"key":"2251_CR66","doi-asserted-by":"publisher","first-page":"re1","DOI":"10.1126\/sageke.2006.6.re1","volume":"2006","author":"DR Thal","year":"2006","unstructured":"Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H (2006) The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowl Environ 2006:re1","journal-title":"Sci Aging Knowl Environ"},{"key":"2251_CR67","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/WNL.58.12.1791","journal-title":"Neurology"},{"key":"2251_CR68","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, R\u00fcb U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K et al (2000) Sequence of A\u03b2-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733\u2013748. https:\/\/doi.org\/10.1093\/jnen\/59.8.733","journal-title":"J Neuropathol Exp Neurol"},{"key":"2251_CR69","doi-asserted-by":"publisher","first-page":"PE26","DOI":"10.1126\/sageke.2004.23.pe26","volume":"2004","author":"DR Thal","year":"2004","unstructured":"Thal DR, Del Tredici K, Braak H (2004) Neurodegeneration in normal brain aging and disease. Sci Aging Knowl Environ 2004:PE26","journal-title":"Sci Aging Knowl Environ"},{"key":"2251_CR70","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1242\/jcs.112.14.2355","volume":"112","author":"B Trinczek","year":"1999","unstructured":"Trinczek B, Ebneth A, Mandelkow EM, Mandelkow E (1999) Tau regulates the attachment\/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci 112:2355\u20132367","journal-title":"J Cell Sci"},{"key":"2251_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5\u201321. https:\/\/doi.org\/10.1038\/nrn.2015.1","journal-title":"Nat Rev Neurosci"},{"key":"2251_CR72","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0197-4580(00)00157-3","volume":"21","author":"CL Weaver","year":"2000","unstructured":"Weaver CL, Espinoza M, Kress Y, Davies P (2000) Conformational change as one of the earliest alterations of tau in Alzheimer\u2019s disease. Neurobiol Aging 21:719\u2013727. https:\/\/doi.org\/10.1016\/S0197-4580(00)00157-3","journal-title":"Neurobiol Aging"},{"key":"2251_CR73","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-018-1922-z","volume":"136","author":"LA Welikovitch","year":"2018","unstructured":"Welikovitch LA, Do Carmo S, Magl\u00f3czky Z, Szocsics P, L\u0151ke J, Freund T et al (2018) Evidence of intraneuronal A\u03b2 accumulation preceding tau pathology in the entorhinal cortex. Acta Neuropathol 136:901\u2013917. https:\/\/doi.org\/10.1007\/s00401-018-1922-z","journal-title":"Acta Neuropathol"},{"key":"2251_CR74","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1062382","volume":"293","author":"CW Wittmann","year":"2001","unstructured":"Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M et al (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293:711\u2013714. https:\/\/doi.org\/10.1126\/science.1062382","journal-title":"Science"},{"key":"2251_CR75","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/jnen\/nly059","volume":"77","author":"H-Y Wu","year":"2018","unstructured":"Wu H-Y, Kuo P-C, Wang Y-T, Lin H-T, Roe AD, Wang BY et al (2018) \u03b2-Amyloid induces pathology-related patterns of tau hyperphosphorylation at synaptic terminals. J Neuropathol Exp Neurol 77:814\u2013826. https:\/\/doi.org\/10.1093\/jnen\/nly059","journal-title":"J Neuropathol Exp Neurol"},{"key":"2251_CR76","doi-asserted-by":"publisher","first-page":"12192","DOI":"10.1074\/jbc.M117.784702","volume":"292","author":"H Zempel","year":"2017","unstructured":"Zempel H, Dennissen FJA, Kumar Y, Luedtke J, Biernat J, Mandelkow EM et al (2017) Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture. J Biol Chem 292:12192\u201312207. https:\/\/doi.org\/10.1074\/jbc.M117.784702","journal-title":"J Biol Chem"},{"key":"2251_CR77","doi-asserted-by":"publisher","first-page":"15295","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, McInnes J, Wierda K, Holt M, Herrmann AG, Jackson RJ et al (2017) Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun 8:15295. https:\/\/doi.org\/10.1038\/ncomms15295","journal-title":"Nat Commun"},{"key":"2251_CR78","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.nbd.2006.01.006","volume":"22","author":"XW Zhou","year":"2006","unstructured":"Zhou XW, Li X, Bjorkdahl C, Sjogren MJ, Alafuzoff I, Soininen H et al (2006) Assessments of the accumulation severities of amyloid \u03b2-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer\u2019s brains. Neurobiol Dis 22:657\u2013668. https:\/\/doi.org\/10.1016\/j.nbd.2006.01.006","journal-title":"Neurobiol Dis"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-020-02251-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:51:25Z","timestamp":1670719885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-020-02251-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1007\/s00401-020-02251-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"4 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DLS is currently an employee of Novartis Oncology Spain. CAFvA received honoraria from serving on the scientific advisory board of Roche (2018\u20132019) and Dr. Willmar Schwabe GmbH & Co. KG (2019) and has received funding for travel and Speaker honoraria from Nutricia GmbH (2014\u20132015), Lilly Deutschland GmbH (2013\u20132016), Biogen (2016\u20132018), Roche (2017\u20132019) and Dr. Willmar Schwabe GmbH & Co. KG (2014\u20132015). RV was PI of the first-in-human trial with 18F-MK6240 (Merck) and global PI of the phase 1 and 2 trials of 18F-flutemetamol (GE). RV\u2019s institution has consultancy agreements (RV as consultant) with Novartis and AC-Immune as well as clinical trial agreements (RV as PI) with AbbVie, Roche, Prevail and Alector. DRT received speaker honorary from Novartis Pharma AG (Switzerland), Biogen (USA), travel reimbursement from GE-Healthcare (UK) and UCB (Belgium) and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}